Evidence map›Paper›PMID 36945372›Full record

ArticlebioRxiv : the preprint server for biology2023

Microglial MHC-I induction with aging and Alzheimer's is conserved in mouse models and humans.

Collyn M Kellogg, Kevin Pham, Adeline H Machalinski, Hunter L Porter, Harris E Blankenship, Kyla Tooley, Michael B Stout, Heather C Rice, Amanda L Sharpe, Michael J Beckstead and 3 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 15 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Collyn M KelloggGenes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.
Kevin PhamGenes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.
Adeline H MachalinskiGenes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.
Hunter L PorterGenes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.
Harris E BlankenshipDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Kyla TooleyGenes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.
Michael B StoutAging & Metabolism Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.
Heather C RiceDepartment of Biochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.
Amanda L SharpeDepartment of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Michael J BecksteadAging & Metabolism Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.
Ana J Chucair-ElliottGenes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.
Sarah R OcañasGenes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.
Willard M FreemanGenes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.
Oklahoma Medical Research Foundation · USUniversity of Oklahoma Health Sciences Center · US

Funding

Visualizing insulin actions on neuronal metabolism and function using fluorescent biosensorsP20GM125528 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Carlos Manlio Diaz Garcia · 2019 to 2026
$17.8M
Targeted DNA Methylation and Mitochondrial Heteroplasmy CoreP30AG050911 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Matthew John Hart · 2015 to 2026
$13.9M
GEROSCIENCE TRAINING PROGRAM IN OKLAHOMAT32AG052363 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Benjamin Francis Miller, William Edmund Sonntag · 2017 to 2026
$3.6M
Sex divergence and cell specificity of age-related hippocampal DNA modificationsR01AG059430 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI FREEMAN, WILLARD M · 2019 to 2023
$2.7M
Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and agingDP5OD033443 · OD · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI OCANAS, SARAH RENEE · 2022 to 2025
$2.2M
Ventral tegmental area involvement in Alzheimer's pathologyR21AG072811 · NIA · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI BECKSTEAD, MICHAEL J · 2021 to 2021
$481k
Multimodal ventral tegmental area decrements in a mouse Alzheimer's modelF31AG079620 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BLANKENSHIP, HARRIS · 2022 to 2024
$110k
Epigenetic regulation of sexually divergent neuroinflammation with brain aging and Alzheimer's diseaseF31AG064861 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI OCANAS, SARAH RENEE · 2019 to 2021
$94k
BLR&D Research Career Scientist Award ApplicationIK6BX005238 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI ARLAN G. RICHARDSON · 2020 to 2026
–
Dynamics of the brain epigenome with agingI01BX003906 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI FREEMAN, WILLARD M · 2018 to 2021
–
BLRD Research Career Scientist Award ApplicationIK6BX006033 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI FREEMAN, WILLARD M · 2022 to 2025
–
Plasticity of GABA input to VTA dopamine neurons in opioid use disordersI01BX005396 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI BECKSTEAD, MICHAEL J · 2022 to 2025
–
BLRD VA I01 BX003906BLRD VA I01 BX005396BLRD VA I01 BX005592BLRD VA IK6 BX006033NIA NIH HHS F31 AG064861NIA NIH HHS F31 AG079620NIA NIH HHS P30 AG050911NIA NIH HHS R01 AG059430NIA NIH HHS R21 AG072811NIA NIH HHS T32 AG052363NIGMS NIH HHS P20 GM125528NIH HHS DP5 OD033443
6 · The paper itself

Abstract

Major Histocompatibility Complex I (MHC-I) CNS cellular localization and function is still being determined after previously being thought to be absent from the brain. MHC-I expression has been reported to increase with brain aging in mouse, rat, and human whole tissue analyses but the cellular localization was undetermined. Neuronal MHC-I is proposed to regulate developmental synapse elimination and tau pathology in Alzheimer's disease (AD). Here we report that across newly generated and publicly available ribosomal profiling, cell sorting, and single-cell data, microglia are the primary source of classical and non-classical MHC-I in mice and humans. Translating Ribosome Affinity Purification-qPCR analysis of 3-6 and 18-22 month old (m.o.) mice revealed significant age-related microglial induction of MHC-I pathway genes

Identifiers

PMID36945372
PMCPMC10028873
OpenAlexW4323830128

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.